Join us for an exciting lecture by Prof. Dr. Manfred Wuhrer from the Leiden University Medical Center

13 November 2024, 2-3 PM
Hybrid

Venue: Karolinska Institute, Air&Fire SciLifeLab Tomtebodavägen 23A Solna

ABOUT THE TOPIC

Glycosylation influences the activity and fate of antibodies and immune cells, playing a key role in infections, inflammatory conditions, and cancer.

Through advanced mass spectrometry approaches, researchers are uncovering disease-associated glycosylation changes, including specific glycans on the Fc portion of antibodies. These modifications can significantly impact antibody functions in autoimmune and alloimmune conditions, as well as in inflammatory and infectious diseases.

Exploring the glycomic landscape of diseases holds great potential for discovering new diagnostic and therapeutic strategies.

ABOUT THE SPEAKER

Prof. Dr. Manfred Wuhrer is professor of Proteomics and Glycomics and head of the Center for Proteomics and Metabolomics of the Leiden University Medical Center (LUMC)). He is also chairman of the Dutch Society for Mass Spectrometry (NVMS).

EUROLIFE DISTINGUISHED LECTURE SERIES

This Eurolife Distinguished Lecture (EDL) is part of the EDL series, which brings top researchers from Eurolife Universities to present groundbreaking work. This will be the first talk in a hybrid format, allowing both in-person and online participation. The series promotes active dialogue between speakers, researchers, and students, enhancing collaboration across partner institutions. Lecture topics span Eurolife’s key research areas, including neuroscience, imaging, cancer, cardiovascular diseases, inflammation, genetics, and international health.

Don't miss this opportunity to gain insights into the cutting-edge research on glycosylation and its implications for diagnostics and therapy!